Interview Intersection: Expert Interviews From January 2025

Samir Mitragotri, PhD, discussed the use of ionic liquids in dermatological therapeutics, highlighting their potential to enhance drug delivery through the skin. CAGE Bio's innovation, CGB-500, demonstrated impressive results in a phase 2a trial for atopic dermatitis, showing a 98% improvement in patients compared to placebo.